1. A Pooled Safety Analysis from the Ustekinumab Crohn's Disease and Psoriatic Diseases Phase 2 and 3 Clinical Trial Programs: 2016 ACG Presidential Poster Award: 662. (October 2016) Authors: Sands, Bruce; Ghosh, Subrata; DeVilliers, Willem; Ott, Elyssa; Gasink, Chris; Lang, Yinghua; Szapary, Philippe; Jacobstein, Doug; Feagan, Brian Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endoscopic Healing in Induction and Maintenance with Ustekinumab in the Phase 3 UNITI Crohn's Disease Program: 2016 ACG Presidential Poster Award: 605. (October 2016) Authors: Sandborn, William J.; Gasink, Chris; Chan, Daphne; Lang, Yinghua; Pollack, Paul; Hanauer, Stephen; Wolf, Douglas; Jacobstein, Doug; Johanns, Jewel; Szapary, Philippe; Feagan, Brian; Rutgeerts, Paul Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1. (March 2016) Authors: Sandborn, William; Gasink, Christopher; Blank, Marion; Lang, Yinghua; Johanns, Jewel; Gao, Long-Long; Sands, Bruce; Hanauer, Stephen; Feagan, Brian; Targan, Stephan; Ghosh, Subrata; de Villiers, Wim; Colombel, Jean-Frédéric; Lee, Scott; Desreumaux, Pierre; Loftus, Edward; Vermeire, Severine; Rutg... Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNα: UNITI-1. (March 2016) Authors: Sandborn, William; Gasink, Christopher; Blank, Marion; Lang, Yinghua; Johanns, Jewel; Gao, Long-Long; Sands, Bruce; Hanauer, Stephen; Feagan, Brian; Targan, Stephan; Ghosh, Subrata; de Villiers, Wim; Colombel, Jean-Frédéric; Lee, Scott; Desreumaux, Pierre; Loftus, Edward; Vermeire, Severine; Rutg... Journal: Inflammatory bowel diseases Issue: Volume 22(2016:Mar.)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohn's Disease: 608. (October 2017) Authors: Sands, Bruce E.; Gasink, Christopher; Jacobstein, Douglas; Ott, Elyssa; Lang, Yinghua; Ramachandran, Paraneedharan; Ghosh, Subrata Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease. (3rd May 2018) Authors: Sands, Bruce E; Han, Chenglong; Gasink, Christopher; Jacobstein, Douglas; Szapary, Philippe; Gao, Long-Long; Lang, Yinghua; Targan, Stephan; Sandborn, William J; Feagan, Brian G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 8(2018:Aug.) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗